W. Breuer, M. Shvartsman, and Z. Cabantchik, Intracellular labile iron, The International Journal of Biochemistry & Cell Biology, vol.40, issue.3, pp.350-354, 2008.
DOI : 10.1016/j.biocel.2007.03.010

H. Hochstrasser, J. Tomiuk, U. Walter, S. Behnke, J. Spiegel et al., Functional relevance of ceruloplasmin mutations in Parkinson's Disease, The FASEB Journal, vol.19, pp.1851-1854, 2005.
DOI : 10.1096/fj.04-3486fje

S. Olivieri, A. Conti, S. Iannaccone, C. Cannistraci, A. Campanella et al., Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron Retention, Journal of Neuroscience, vol.31, issue.50, pp.18568-77, 2011.
DOI : 10.1523/JNEUROSCI.3768-11.2011

S. Ayton, P. Lei, J. Duce, B. Wong, A. Sedjahtera et al., Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease, Annals of Neurology, vol.37, issue.4, pp.554-563, 2013.
DOI : 10.1002/ana.23817

M. Boll, J. Sotelo, E. Otero, M. Alcaraz-zubeldia, and C. Rios, Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease, Neuroscience Letters, vol.265, issue.3, pp.155-163, 1999.
DOI : 10.1016/S0304-3940(99)00221-9

H. Hochstrasser, P. Bauer, U. Walter, S. Behnke, J. Spiegel et al., Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease, Neurology, vol.63, issue.10, pp.1912-1919, 2004.
DOI : 10.1212/01.WNL.0000144276.29988.C3

A. Friedman and J. Galazka-friedman, The history of the research of iron in parkinsonian substantia nigra, Journal of Neural Transmission, vol.101, issue.12, pp.1507-1517, 2012.
DOI : 10.1007/s00702-012-0894-8

Z. Cabantchik, A. Munnich, M. Youdim, and D. Devos, Regional siderosis: a new challenge for iron chelation therapy, Frontiers in Pharmacology, vol.4, p.167, 2013.
DOI : 10.3389/fphar.2013.00167

D. Devos, C. Moreau, J. Devedjian, J. Kluza, M. Petrault et al., Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease, Antioxidants & Redox Signaling, vol.21, issue.2, pp.195-210, 2014.
DOI : 10.1089/ars.2013.5593

K. Schosinsky, H. Lehmann, and M. Beeler, Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride, Clin Chem, vol.20, pp.1556-63, 1974.

S. Mart?nez-subiela, F. Tecles, and J. Ceron, Comparison of two automated spectrophotometric methods for ceruloplasmin measurement in pigs, Research in Veterinary Science, vol.83, issue.1, pp.12-21, 2007.
DOI : 10.1016/j.rvsc.2006.10.011

M. Siotto, P. Pasqualetti, M. Marano, and R. Squitti, Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson???s disease and in hepatic encephalopathy, Journal of Neural Transmission, vol.59, issue.1, pp.1281-1287, 2014.
DOI : 10.1007/s00702-014-1196-0